G6PD and autoimmune hemolytic anemia: In contrast, the G6PD Mediterranean variant, which is common across southern Italy (particularly Sardinia) and the Arabian Peninsula[34], exhibits exceedingly low residual enzyme activity (<1%[35]) and predisposes individuals to favism[36,37] and clinically severe AHA following primaquine therapy[12,35,38,39].